Puma Biotechnology (PBYI) Inventory Average (2017 - 2026)

Puma Biotechnology's Inventory Average history runs 10 years deep, the most recent figure standing at $7.1 million for Q1 2026.

• Quarterly Inventory Average fell 18.7% year-over-year to $7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.1 million (down 18.7% YoY) and the FY2025 annual result came in at $7.1 million, down 9.9% from the prior year.
• Inventory Average was $7.1 million for Q1 2026 at Puma Biotechnology, down from $7.5 million in the prior quarter.
• Across five years, Inventory Average topped out at $9.0 million in Q3 2025 and bottomed at $4.2 million in Q1 2023.
• A 5-year average of $6.8 million and a median of $7.0 million in 2022 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average tumbled 41.49% — and 2024, when it jumped 68.47%.
• Puma Biotechnology's Inventory Average stood at $5.0 million in 2022, then climbed by 27.87% to $6.4 million in 2023, then decreased by 10.67% to $5.7 million in 2024, then surged by 31.53% to $7.5 million in 2025, then dropped by 5.22% to $7.1 million in 2026.
• Business Quant data shows PBYI's Inventory Average at $7.1 million in Q1 2026, $7.5 million in Q4 2025, and $9.0 million in Q3 2025.